Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group (Q33496743)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group |
scientific article |
Statements
1 reference
Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group (English)
1 reference
D Macdonald
1 reference
G Cairncross
1 reference
D Stewart
1 reference
P Forsyth
1 reference
C Sawka
1 reference
N Wainman
1 reference
E Eisenhauer
1 reference
1 February 1996
1 reference
1 reference
Identifiers
1 reference